XML 38 R22.htm IDEA: XBRL DOCUMENT v3.22.1

Collaboration Agreements And Business Development Activities (Tables)

3 Months Ended

Apr. 01, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Collaborative Revenues Under Collaboration Agreement

Revenues under the collaboration agreement with Ipsen were as follows (in thousands):

			Three Months Ended March 31,
			2022						2021
License revenues			$	24,614					$	22,451
Collaboration services revenues			9,913						11,355
Total			$	34,527					$	33,806

Revenues under the collaboration agreement with Takeda were as follows (in thousands):

			Three Months Ended March 31,
			2022						2021
License revenues			$	2,365					$	1,301
Collaboration services revenues			3,702						4,135
Total			$	6,067					$	5,436

License revenues under the collaboration agreement with Genentech were as follows (in thousands):

			Three Months Ended March 31,
			2022						2021
Profits on U.S. commercialization			$	2,139					$	1,794
Royalty revenues on ex-U.S. sales			$	1,628					$	951

X

- References

No definition available.

+ Details

Name:	us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 808
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434

+ Details

Name:	us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration